The effect of iron dosing schedules on plasma hepcidin and iron absorption in Kenyan infants. Issue 4 (17th July 2020)
- Record Type:
- Journal Article
- Title:
- The effect of iron dosing schedules on plasma hepcidin and iron absorption in Kenyan infants. Issue 4 (17th July 2020)
- Main Title:
- The effect of iron dosing schedules on plasma hepcidin and iron absorption in Kenyan infants
- Authors:
- Uyoga, Mary A
Mikulic, Nadja
Paganini, Daniela
Mwasi, Edith
Stoffel, Nicole U
Zeder, Christophe
Karanja, Simon
Zimmermann, Michael B - Abstract:
- ABSTRACT: Background: In adults, oral iron doses increase plasma hepcidin (PHep) for 24 h, but not for 48 h, and there is a circadian increase in PHep over the day. Because high PHep decreases fractional iron absorption (FIA), alternate day iron dosing in the morning may be preferable to consecutive day dosing. Whether these effects occur in infants is uncertain. Objective: Using stable iron isotopes in Kenyan infants, we compared FIA from morning and afternoon doses and from consecutive, alternate (every second day) and every third day iron doses. Methods: In prospective studies, we measured and compared FIA and the PHep response from 1 ) meals fortified with a 12-mg iron micronutrient powder given in the morning or afternoon ( n = 22); 2 ) the same given on consecutive or alternate days ( n = 21); and 3 ) a 12-mg iron supplement given on alternate days or every third day ( n = 24). Results: In total, 65.7% of infants were anemic. In study 1, PHep did not differ between morning and afternoon ( P = 0.072), and geometric mean FIA[−SD, +SD](%) did not differ between the morning and afternoon doses [15.9 (8.9, 28.6) and 16.1 (8.7, 29.8), P = 0.877]. In study 2, PHep was increased 24 h after oral iron ( P = 0.014), and mean FIA [±SD](%) from the baseline dose [23.3 (10.9)] was greater than that from the consecutive day dose (at 24 h) [20.1 (10.4); P = 0.042] but did not differ from the alternate day dose (at 48 h) [20.9 (13.4); P = 0.145]. In study 3, PHep was notABSTRACT: Background: In adults, oral iron doses increase plasma hepcidin (PHep) for 24 h, but not for 48 h, and there is a circadian increase in PHep over the day. Because high PHep decreases fractional iron absorption (FIA), alternate day iron dosing in the morning may be preferable to consecutive day dosing. Whether these effects occur in infants is uncertain. Objective: Using stable iron isotopes in Kenyan infants, we compared FIA from morning and afternoon doses and from consecutive, alternate (every second day) and every third day iron doses. Methods: In prospective studies, we measured and compared FIA and the PHep response from 1 ) meals fortified with a 12-mg iron micronutrient powder given in the morning or afternoon ( n = 22); 2 ) the same given on consecutive or alternate days ( n = 21); and 3 ) a 12-mg iron supplement given on alternate days or every third day ( n = 24). Results: In total, 65.7% of infants were anemic. In study 1, PHep did not differ between morning and afternoon ( P = 0.072), and geometric mean FIA[−SD, +SD](%) did not differ between the morning and afternoon doses [15.9 (8.9, 28.6) and 16.1 (8.7, 29.8), P = 0.877]. In study 2, PHep was increased 24 h after oral iron ( P = 0.014), and mean FIA [±SD](%) from the baseline dose [23.3 (10.9)] was greater than that from the consecutive day dose (at 24 h) [20.1 (10.4); P = 0.042] but did not differ from the alternate day dose (at 48 h) [20.9 (13.4); P = 0.145]. In study 3, PHep was not increased 48 and 72 h after oral iron ( P = 0.384), and the geometric mean FIA[−SD, +SD](%) from doses given at baseline, alternate days, and every third day did not differ [12.7 (7.3, 21.9), 13.8 (7.8, 24.2), and 14.8 (8.8, 24.8), respectively; P = 0.080]. Conclusions: In Kenyan infants given 12 mg oral iron, morning and afternoon doses are comparably absorbed, dosing on consecutive days increases PHep and modestly decreases iron absorption compared with alternate day dosing, and dosing on alternate days or every third day does not increase PHep or decrease absorption. This trial was registered at clinicaltrials.gov as NCT02989311 and NCT03617575. … (more)
- Is Part Of:
- American journal of clinical nutrition. Volume 112:Issue 4(2020)
- Journal:
- American journal of clinical nutrition
- Issue:
- Volume 112:Issue 4(2020)
- Issue Display:
- Volume 112, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 112
- Issue:
- 4
- Issue Sort Value:
- 2020-0112-0004-0000
- Page Start:
- 1132
- Page End:
- 1141
- Publication Date:
- 2020-07-17
- Subjects:
- iron -- absorption -- hepcidin -- stable isotopes -- Kenya -- infants -- micronutrient powders -- iron supplement -- dosing regimen
Diet therapy -- Periodicals
Nutrition -- Periodicals
Dietetics -- Periodicals
613.205 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/ajcn/ ↗
https://www.sciencedirect.com/journal/the-american-journal-of-clinical-nutrition ↗
https://ajcn.nutrition.org/ ↗ - DOI:
- 10.1093/ajcn/nqaa174 ↗
- Languages:
- English
- ISSNs:
- 0002-9165
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0823.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14861.xml